Bacil Pharma Ltd Receives Name Approval from Ministry of Corporate Affairs for Proposed Subsidiary
Bacil Pharma Ltd has received approval from the Registrar of Companies, Central Registration Centre (CRC), Ministry of Corporate Affairs, regarding the proposed name for its new wholly-owned subsidiary. The approved name is 'Bacil Research & Development Private Limited'.The approval granted by the CRC indicates that the company can proceed with the incorporation process for the new entity. Bacil Pharma Ltd stated that while the name has been officially approved, the full incorporation of the subsidiary is currently underway.
The Central Registration Centre (CRC) provided the name availability certificate, confirming that 'Bacil Research & Development Private Limited' was available for registration. The reservation period for this name is valid until 26/07/2026.
The company indicated it will make further disclosures upon the successful completion of the incorporation and the receipt of the Certificate of Incorporation from the Registrar of Companies.
Stock Price Movement
Bacil Pharma Ltd settled on Tuesday at ₹38.61, dipping by 1.96%. The shares moved through an intraday range that stretched from a low of ₹37.72 to a high of ₹39.99.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.